Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome ; volume:27 ; number:1 ; day:11 ; month:5 ; year:2021 ; pages:1-13 ; date:12.2021
Molecular medicine ; 27, Heft 1 (11.5.2021), 1-13, 12.2021
- Urheber
-
Palmblad, Karin
Schierbeck, Hanna
Sundberg, Erik
Horne, Anna-Carin
Erlandsson Harris, Helena
Henter, Jan-Inge
Andersson, Ulf
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-021-00308-0
- URN
-
urn:nbn:de:101:1-2021091207074322044783
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Palmblad, Karin
- Schierbeck, Hanna
- Sundberg, Erik
- Horne, Anna-Carin
- Erlandsson Harris, Helena
- Henter, Jan-Inge
- Andersson, Ulf
- SpringerLink (Online service)
Ähnliche Objekte (12)
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
Cytokine active disulfide-HMGB1 increased during severe macrophage activation syndrome
NK cell HMGB1 mediates IL-2-induced “systemic autophagic” toxicity
Molecular mechanisms of etoposide
Downregulation of HMGB1 carried by macrophage-derived extracellular vesicles delays atherosclerotic plaque formation through Caspase-11-dependent macrophage pyroptosis
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis
Systemic immune profile in Prader-Willi syndrome: elevated matrix metalloproteinase and myeloperoxidase and reduced macrophage inhibitory factor
Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome
Alarmin HMGB1 induces systemic and brain inflammatory exacerbation in post-stroke infection rat model
Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
Cytokine active disulfide-HMGB1 increased during severe macrophage activation syndrome
NK cell HMGB1 mediates IL-2-induced “systemic autophagic” toxicity
Molecular mechanisms of etoposide
Downregulation of HMGB1 carried by macrophage-derived extracellular vesicles delays atherosclerotic plaque formation through Caspase-11-dependent macrophage pyroptosis
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis
Systemic immune profile in Prader-Willi syndrome: elevated matrix metalloproteinase and myeloperoxidase and reduced macrophage inhibitory factor
Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome
Alarmin HMGB1 induces systemic and brain inflammatory exacerbation in post-stroke infection rat model
Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
Cytokine active disulfide-HMGB1 increased during severe macrophage activation syndrome
NK cell HMGB1 mediates IL-2-induced “systemic autophagic” toxicity
Molecular mechanisms of etoposide
Downregulation of HMGB1 carried by macrophage-derived extracellular vesicles delays atherosclerotic plaque formation through Caspase-11-dependent macrophage pyroptosis
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis
Systemic immune profile in Prader-Willi syndrome: elevated matrix metalloproteinase and myeloperoxidase and reduced macrophage inhibitory factor
Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome
Alarmin HMGB1 induces systemic and brain inflammatory exacerbation in post-stroke infection rat model